Back to 
HBK INVESTMENTS L P
HBK INVESTMENTS L P
TAKShowing 0 of 4 quarters
Position history for HBK INVESTMENTS L P's holdings in TAKEDA PHARMACEUTICAL CO LTD
No. HBK Investments exited its TAK (Takeda Pharmaceutical) position in Q4 2019. Its Q3 2019 13F listed 2,637,550 shares worth $45.4M. HBK Investments already held TAK in its Q1 2019 13F, the earliest on record, and held it in 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, Capital Research Global Investors